SIGYN THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $0.00.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $1.47M.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2018-09-30 was $0.00.
- SIGYN THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $610.18K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-14 | $214.55K 10-Q · filed 2025-11-14 |
| 2021-06-30 | $1.47M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $610.18K 10-K · filed 2022-03-21 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 |